Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData Read more
Second wave of COVID-19 vaccines may not be needed to reach higher efficacy bar than first batch Read more
India’s role in global supply of COVID-19 drugs and vaccines remains crucial despite IPR waiver decision: GlobalData Read more
Vaccine trials outside home market will help Chinese firms capture Asia, South and Central America markets: GlobalData Read more
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment Read more